Recent Finacing
Recent Raise
On-Q-ity develops CTC capture and predictive biomarker platforms to analyze tumor tissue and circulating cells for minimally invasive, real-time monitoring of therapy response and recurrence.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors